Domov › Rakovina endometria › Minnesota

Klinické štúdie Rakovina endometria v štáte Minnesota

39 štúdií pre Rakovina endometria hľadá účastníkov v zariadeniach v štáte Minnesota.

Mestá v štáte Minnesota

Oficiálny text štúdie (anglicky)

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Sanford Joe Lueken Cancer Center, Bemidji
Mercy Hospital, Coon Rapids
Essentia Health - Deer River Clinic, Deer River
a 12 ďalších

Prebieha náborFáza 2

Všetky vekové kategórie · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT05564377

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Essentia Health Saint Joseph's Medical Center, Brainerd
Mercy Hospital, Coon Rapids
Essentia Health - Deer River Clinic, Deer River
a 11 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Ženy · Aktualizované 2. 10. 2026 · NCT07198074

A Phase 1 Study of the Safety and Tolerability of CTX-10726

Mayo Clinic Rochester, Rochester

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT07419841

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Health Partners Frauenshuh Cancer Center, Saint Louis Park
Health Partners Cancer Center at Regions Hospital, Saint Paul

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT06172478

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

Mayo Clinic, Rochester

Prebieha náborObservačná štúdia

Vek 18 a viac · Ženy · Aktualizované 29. 9. 2026 · NCT05051722

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

Mercy Hospital, Coon Rapids
Essentia Health - Deer River Clinic, Deer River
Essentia Health Cancer Center, Duluth
a 11 ďalších

Prebieha náborFáza 2

Vek 18 a viac · Ženy · Aktualizované 28. 9. 2026 · NCT05112601

Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers

Mayo Clinic - Rochester, Rochester

Prebieha náborFáza 1/2

Vek 18 a viac · Ženy · Aktualizované 25. 9. 2026 · NCT03564340

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

Mercy Hospital, Coon Rapids

Prebieha náborFáza 2

Vek 18 a viac · Ženy · Aktualizované 24. 9. 2026 · NCT05640999

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

Minnesota Oncology Hematology, PA ( Site 8003), Minneapolis

Prebieha náborFáza 3

Vek 18 a viac · Ženy · Aktualizované 17. 9. 2026 · NCT06952504

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Mayo Rochester, Rochester

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 9. 2026 · NCT07109726

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Mayo Clinic (Rochester), Rochester

Prebieha náborObservačná štúdia

Vek 18 a viac · Všetky pohlavia · Aktualizované 14. 9. 2026 · NCT05059444

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

USOR - Minnesota Oncology-Coon Rapids Clinic, Coon Rapids
USOR - Minnesota Oncology/ Coon Rapids Clinic, Coon Rapids
USOR - Minnesota Oncology - Edina Clinic, Edina
a 7 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Ženy · Aktualizované 9. 9. 2026 · NCT07166094

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Research Site, Marshall
Research Site, Minneapolis
Research Site, Rochester

Prebieha náborFáza 3

Vek 18 a viac · Ženy · Aktualizované 3. 9. 2026 · NCT06989112

FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

University of Minnesota Masonic Cancer Center, Minneapolis

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 9. 2026 · NCT07216105

Flyte Device for Improving Urinary Incontinence Among Endometrial and Cervical Cancer Survivors Who Have Undergone Radiation Therapy

Mayo Clinic in Rochester, Rochester

Prebieha nábor

Vek 21 a viac · Ženy · Aktualizované 31. 8. 2026 · NCT07662824

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

University of Minnesota, Minneapolis

Prebieha náborFáza 1

Vek 15 a viac · Všetky pohlavia · Aktualizované 25. 8. 2026 · NCT06276491

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

University of Minnesota/Masonic Cancer Center, Minneapolis

Prebieha náborFáza 1/2

12 Months – 30 Years · Všetky pohlavia · Aktualizované 25. 8. 2026 · NCT04851119

Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer

Mayo Clinic in Rochester, Rochester

Prebieha nábor

Vek 18 a viac · Ženy · Aktualizované 19. 8. 2026 · NCT04567771

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

Normunity Investigational Site, Minneapolis

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 8. 2026 · NCT07182149

FOG-001 in Locally Advanced or Metastatic Solid Tumors

M Health Fairview University of Minnesota Medical Center, Minneapolis
Mayo Clinic, Rochester

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 8. 2026 · NCT05919264

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

M Health Fairview University of Minnesota Medical Center, Minneapolis

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 5. 8. 2026 · NCT06330064

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

USOR Minnesota Oncology Hematology, Maplewood

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 4. 8. 2026 · NCT05579366

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Minnesota Oncology Hematology, Maple Grove
Mayo Clinic (Minnesota), Rochester

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 7. 2026 · NCT04657068

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

Research Site, Minneapolis

Prebieha náborFáza 3

Vek 18 a viac · Ženy · Aktualizované 29. 7. 2026 · NCT07044336

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

518, Minneapolis

Prebieha náborFáza 2

Vek 18 a viac · Ženy · Aktualizované 16. 7. 2026 · NCT06906341

Acceptability of Testing DNA Markers in Vaginal Fluid for the Detection of Endometrial Cancer

Mayo Clinic in Rochester, Rochester

Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov

Vek 45 a viac · Ženy · Aktualizované 9. 7. 2026 · NCT07527143

Integrated Cancer Repository for Cancer Research

Riverwood Healthcare Center, Aitkin
Essentia Health-St. Joseph's Medical Center, Brainerd
Essentia Health - Duluth Clinic, Duluth
a 2 ďalších

Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov

Vek 19 až 110 · Všetky pohlavia · Aktualizované 29. 6. 2026 · NCT02012699

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

Mayo Clinic - Rochester, Rochester

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 29. 6. 2026 · NCT05377996

Non-Invasive Identification of Endometrial Cancer/Endometrial Atypical Hyperplasia With an AI-Based Classifier Applied to Transvaginal Ultrasound in Patients With Post-Menopausal Bleeding

Mayo Clinic in Rochester, Rochester

Prebieha náborObservačná štúdia

Vek 55 a viac · Ženy · Aktualizované 10. 6. 2026 · NCT06365905

Molecular and ctDNA Characterization of High-Risk Endometrial Cancer

Mayo Clinic in Rochester, Rochester

Prebieha náborObservačná štúdia

Vek 18 a viac · Ženy · Aktualizované 13. 4. 2026 · NCT07062016

Avera Cancer Sequencing and Analytics Protocol (ASAP)

Avera Cancer Institute - Marshall, Marshall

Prebieha náborObservačná štúdia

Vek 18 a viac · Všetky pohlavia · Aktualizované 27. 3. 2026 · NCT05142033

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

Mayo Clinic, Rochester

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 27. 3. 2026 · NCT06395519

Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform

Mayo Clinic in Rochester, Rochester

Prebieha náborObservačná štúdia

Vek 18 a viac · Všetky pohlavia · Aktualizované 12. 3. 2026 · NCT06349642

Screening and Staging of Benign vs Malignant Pelvic Abnormalities

Mayo Clinic in Rochester, Rochester

Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov

Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 2. 2026 · NCT07407959

First in Human Study of TORL-1-23 in Participants With Advanced Cancer

University of Minnesota, Minneapolis
Mayo Clinic in Rochester, Rochester

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 13. 2. 2026 · NCT05103683

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Allina Health Cancer Institute, Minneapolis
Mayo Clinic, Rochester

Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov

Vek 40 a viac · Všetky pohlavia · Aktualizované 20. 1. 2026 · NCT05366881

Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer

Minnesota Oncology Hematology, P.A., Maple Grove

Prebieha náborFáza 2

Vek 18 a viac · Ženy · Aktualizované 24. 12. 2025 · NCT06463028

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Duluth

Prebieha náborObservačná štúdia

Všetky vekové kategórie · Všetky pohlavia · Aktualizované 28. 10. 2025 · NCT03452774

Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer

Minnesota Oncology Hematology, P.A., Minneapolis

Prebieha náborFáza 2/3

Vek 18 a viac · Ženy · Aktualizované 2. 5. 2024 · NCT05797831

Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.